Dragonfly's TriNKET compounds are designed to activate and direct NK and cytotoxic T cell killing against cancer cells. The platform has also attracted partnerships from other pharma groups ...

Physical exercise plays an important role in controlling disease, including cancer, due to its effect on the human body’s ...

The researchers believe this finding opens the door to new drug therapies that activate cancer fighting cells—called ...

Caribou cuts NK cell therapy program, lays off 12% of staff to fund CAR-T priorities Efforts to use antibodies to recruit immune cells to fight cancer and other diseases have been on the rise ...

Base Therapeutics has announced that its NK510 cell injection, the world's first zero-off-target base-edited NK cell product, has received IND approvals from both the U.S. FDA and China's NMPA for ...

They provide convincing evidence for the effectiveness of IL-15/12-conditioned NK cells in this design, which was also critical for the authors being able to conclusively reveal the T cell-dependency ...

A research team behind a new study at the Hebrew University of Jerusalem has made an important breakthrough in understanding how immune cells known as T cells are activated. By using an innovative ...

Dec. 11, 2024 — Gut microbiome composition during pregnancy has long-term effects on offspring stem cell growth and development, researchers report. Treating pregnant mice with a common gut ...

Base Therapeutics announced that its in house-developed NK510 cell injection—the world’s first base-edited universal NK cell product—has received IND approvals in both China and the United States.